Cargando…
Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
Autores principales: | Boven, E., Erkelens, C. A., Luning, M., Pinedo, H. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971603/ https://www.ncbi.nlm.nih.gov/pubmed/2337508 |
Ejemplares similares
-
Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials Committee.
por: Kaye, S. B., et al.
Publicado: (1992) -
NSC-derived exosomes enhance therapeutic effects of NSC transplantation on cerebral ischemia in mice
por: Zhang, Ruolin, et al.
Publicado: (2023) -
GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life
por: Louw, Ann
Publicado: (2019) -
Endothelial cell secreted VEGF-C enhances NSC VEGFR3 expression and promotes NSC survival
por: Matta, Rita, et al.
Publicado: (2021) -
Role of NSC319726 in ovarian cancer based on the bioinformatics analyses
por: Xue, Ji, et al.
Publicado: (2015)